Shilpa Gupta: Amazing to see our first patient enrolled on EV-302 still in complete remission after 3 years
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared on LinkedIn:
“Amazing to see our first patient enrolled on EV-302 (EV and Pembrolizumab arm) still in complete remission after 3 years featured in our Case Western Reserve University Annual Report 2023.
‘To enjoy my grandchildren, family, and travel -the study has been all I could ask for.’
EV and Pembrolizumab sets the bar high for efficacy and quality of life in urothelial cancer.
Thanks to our patients and team at Cleveland Clinic for making this study a success.”
Read further.
Source: Shilpa Gupta/LinkedIn
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023